These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 16279620)

  • 1. [Mechanism of abnormal thyroid cell proliferation in normal and tumor tissues].
    Isozaki O
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():153-8. PubMed ID: 16279620
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
    Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
    Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.
    Zaballos MA; Santisteban P
    Mol Endocrinol; 2013 Jan; 27(1):50-62. PubMed ID: 23160481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesis.
    Uyttersprot N; Allgeier A; Baptist M; Christophe D; Coppee F; Coulonval K; Deleu S; Depoortere F; Dremier S; Lamy F; Ledent C; Maenhaut C; Miot F; Panneels V; Parma J; Parmentier M; Pirson I; Pohl V; Roger P; Savonet V; Taton M; Tonacchera M; van Sande J; Wilkin F; Vassart G
    Adv Second Messenger Phosphoprotein Res; 1997; 31():125-40. PubMed ID: 9344247
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of bone mass by PI3 kinase/Akt signaling].
    Kawamura N; Kawaguchi H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():67-70. PubMed ID: 18161083
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of insulin-like growth factor I-mediated proliferation of adult neural progenitor cells: role of Akt.
    Kalluri HS; Vemuganti R; Dempsey RJ
    Eur J Neurosci; 2007 Feb; 25(4):1041-8. PubMed ID: 17331200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated RET signaling in thyroid cancer.
    Castellone MD; Santoro M
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):363-74, viii. PubMed ID: 18502331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells.
    Tosca L; Ramé C; Chabrolle C; Tesseraud S; Dupont J
    Reproduction; 2010 Feb; 139(2):409-18. PubMed ID: 19906888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.
    Fedele M; Palmieri D; Chiappetta G; Pasquinelli R; De Martino I; Arra C; Palma G; Valentino T; Pierantoni GM; Viglietto G; Rothstein JL; Santoro M; Fusco A
    Endocr Relat Cancer; 2009 Jun; 16(2):483-90. PubMed ID: 19261681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
    Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
    Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.
    Gujral TS; van Veelen W; Richardson DS; Myers SM; Meens JA; Acton DS; Duñach M; Elliott BE; Höppener JW; Mulligan LM
    Cancer Res; 2008 Mar; 68(5):1338-46. PubMed ID: 18316596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways.
    Levine AJ; Feng Z; Mak TW; You H; Jin S
    Genes Dev; 2006 Feb; 20(3):267-75. PubMed ID: 16452501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin.
    Coulonval K; Vandeput F; Stein RC; Kozma SC; Lamy F; Dumont JE
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):351-8. PubMed ID: 10816429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid growth factors, signal transduction pathways, and oncogenes.
    Duh QY; Grossman RF
    Surg Clin North Am; 1995 Jun; 75(3):421-37. PubMed ID: 7747250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and proliferation of the thyroid cell in normal physiology and in disease.
    Dumont JE; Maenhaut C; Lamy F; Pirson I; Clement S; Roger PP
    Ann Endocrinol (Paris); 2003 Feb; 64(1):10-1. PubMed ID: 12707625
    [No Abstract]   [Full Text] [Related]  

  • 18. The thyrotropin receptor and the regulation of thyrocyte function and growth.
    Vassart G; Dumont JE
    Endocr Rev; 1992 Aug; 13(3):596-611. PubMed ID: 1425489
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the growth of normal and neoplastic thyroid tissue.
    Duh QY; Clark OH
    Surg Clin North Am; 1987 Apr; 67(2):281-98. PubMed ID: 3031835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Editorial Klotz thyroid].
    Wémeau JL
    Ann Endocrinol (Paris); 2011 Apr; 72(2):53-4. PubMed ID: 21513915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.